2024年10月4日下午,微创医疗(00853.HK)股价大涨5.08%,最新报价8.890港元/股,成交量1029.37万股,引发市场关注。
虽然当日缺乏直接导致股价大涨的重磅利好,但分析人士认为,投资者对微创医疗的长期业绩和增长前景保持乐观。财报显示,公司最新营收43.63亿港元,尽管净利润出现亏损7.56亿港元,但其较高的毛利率25.81亿港元表明公司产品获得一定市场认可。此外,80%机构均给予公司"买入"至"持有"评级,反映看好公司未来发展潜力。
行业数据显示,微创医疗所处医疗设备及用品板块整体小幅上涨0.14%,个股表现向好。微创医疗作为医疗器械领域的龙头企业,从事产品研发及销售,涵盖骨科、心血管、外科等多个细分领域,受益前景被资金青睐。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.